REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

osauhing Folia Apteek (Estonia)

Main Activities: Pharmacies and Drug Stores
Full name: osauhing Folia Apteek Profile Updated: November 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

osauhing Folia Apteek is based in Estonia. The head office is in Turi. The company operates in the Pharmacies and Drug Stores sector. It was first established on November 18, 1996. 7 (2024) employees currently work for osauhing Folia Apteek. There was a net sales revenue increase of 6.79% reported in osauhing Folia Apteek’s latest financial highlights for 2024. During that time, osauhing Folia Apteek’s total assets decreased by 14.64%. osauhing Folia Apteek’s net profit margin increased by 0.35% in 2024.

Headquarters
Viljandi tn 26 Turi linn
Turi; Jarva county; Postal Code: 72212

Contact Details: Purchase the osauhing Folia Apteek report to view the information.

Basic Information
Total Employees:
Purchase the osauhing Folia Apteek report to view the information.
Registered Capital:
Purchase the osauhing Folia Apteek report to view the information.
Financial Auditors:
Purchase the osauhing Folia Apteek report to view the information.
Incorporation Date:
November 18, 1996
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after osauhing Folia Apteek report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
6.79%▲
Total operating revenue
6.79%▲
Operating profit (EBIT)
33.41%▲
EBITDA
21.09%▲
Net Profit (Loss) for the Period
35.21%▲
Total assets
-14.64%▼
Total equity
-32.23%▼
Operating Profit Margin (ROS)
0.5%▲
Net Profit Margin
0.35%▲
Return on Equity (ROE)
13.63%▲
Cash Ratio
-0.13%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo